Tissue-Specific shRNA delivery: A novel approach for gene therapy in cancer

Connective Tissue Research

Volumn 49, Issue 3-4, 2008, Pages 265-269

  Ghatak, Shilenath ^a   Hascall, Viacent ^b   Berger, Franklin ^c   Penas, Maria M O ^c   Davis, Celestia ^c   Jabari, Esmaiel ^c   He, Xuezhong ^c   Norris, James ^a   Dang, Yujing ^a   Markwald, Roger R ^a   Misra, Suniti ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cancer; CD44shRNA; Hyaluronan; Nanoparticle; Plasmid delivery

Indexed keywords

CRE RECOMBINASE; HERMES ANTIGEN; HYALURONIC ACID; NANOPARTICLE; OLIGONUCLEOTIDE; SHORT HAIRPIN RNA; TRANSFERRIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER THERAPY; CANCER TISSUE; CELL PROLIFERATION; CELL SURVIVAL; COLON CANCER; ENDOCYTOSIS; EXON; EXPRESSION VECTOR; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PLASMID; PROSTATE CANCER; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD44; BREAST NEOPLASMS; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; HYALURONIC ACID; INTEGRASES; MALE; NANOPARTICLES; NEOPLASMS; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 48549089331     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200802147845     Document Type: Article

References (29)

1. Matzke, M. A. and Birchler, J. A. (2005) RNAi-mediated pathways in the nucleus. 6, pp. 24-35.
2. Napoli, C., Lemieux, C. and Jorgensen, R. (1990) Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. 2, pp. 279-289.
3. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E. and Mello, C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. 391, pp. 806-811.
4. Kennerdell, J. R. and Carthew, R. W. (2000) Heritable gene silencing in Drosophila using double-stranded RNA. 18, pp. 896-898.
5. Aigner, A. (2006) Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo. p. 71659.
6. Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K. Davis, C. R. et al. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. 441, pp. 537-541.
7. Turley, E. A. (1989) The Biology of Hyaluronan. 121, J.Wiley & Sons, Ltd., Chichester, U.K.
8. Toole, B. P. (2004) Hyaluronan: From extracellular glue to pericellular cue. 4, pp. 528-539.
9. Ghatak, S., Misra, S. and Toole, B. P. (2002) Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. 77, pp. 38013-38020.
10. Knudson, C. B. and Knudson, W. (1993) Hyaluronan-binding proteins in development, tissue homeostasis, and disease. 7, pp. 1233-1241.
11. Entwistle, J., Hall, C. L. and Turley, E. A. (1996) HA receptors: regulators of signalling to the cytoskeleton. 61, pp. 569-577.
12. Campbell, P., Laurent, T. C. and Roden, L. (1987) Assay and properties of N-acetylglucosamine-6-phosphate deacetylase from rat liver. 166, pp. 134-141.
13. Hua, Q., Knudson, C. B. and Knudson, W. (1993) Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. 106, pp. 365-375.
14. Ponta, H., Sherman, L. and Herrlich, P. A. (2003) CD44: From adhesion molecules to signalling regulators. 4, pp. 33-45.
15. Nakazawa, H., Yoshihara, S., Kudo, D., Morohashi, H., Kakizaki, I. Kon, A. et al. (2006) 4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells. 57, pp. 165-170.
16. Ghatak, S., Misra, S. and Toole, B. P. (2005) Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. 280, pp. 8875-8883.
17. Misra, S., Toole, B. P. and Ghatak, S. (2006) Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. 281, pp. 34936-34941.
18. Mike, S., Harrison, C., Coles, B., Staffurth, J., Wilt, T. J. and Mason, M. D. (2006) Chemotherapy for hormone-refractory prostate cancer. p. CD005247.
19. Welsh, C. F., Zhu, D. and Bourguignon, L. Y. (1995) Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. 164, pp. 605-612.
20. Omara-Opyene, A. L., Qiu, J., Shah, G. V. and Iczkowski, K. A. (2004) Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18. 84, pp. 894-907.
21. Gupta, R. A. and Dubois, R. N. (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. 1, pp. 11-21.
22. Dohadwala, M., Luo, J., Zhu, L., Lin, Y., Dougherty, G. J. Sharma, S. et al. (2001) Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. 276, pp. 20809-20812.
23. Reeder, J. A., Gotley, D. C., Walsh, M. D., Fawcett, J. and Antalis, T. M. (1998) Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. 58, pp. 3719-3726.
24. Ruponen, M., Honkakoski, P., Tammi, M. and Urtti, A. (2004) Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. 6, pp. 405-414.
25. Ruponen, M., Ronkko, S., Honkakoski, P., Pelkonen, J., Tammi, M. and Urtti, A. (2001) Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. 276, pp. 33875-33880.
26. Eliaz, R. E. and Szoka, F.C. Jr. (2001) Liposome-encapsulated doxorubicin targeted to CD44: A strategy to kill CD44-overexpressing tumor cells. 61, pp. 2592-2601.
27. Haapala, J., Arokoski, J. P., Ronkko, S., Agren, U., Kosma, V. M. Lohmander, L. S. et al. (2001) Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs. 60, pp. 55-60.
28. Ventura, A., Meissner, A., Dillon, C. P., McManus, M., Sharp, P. A. Van Parijs, L. et al. (2004) Cre-lox-regulated conditional RNA interference from transgenes. 101, pp. 10380-10385.
29. Moser, A. R., Pitot, H. C. and Dove, W. F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. 247, pp. 322-324.